Leo Pharma Products

LEO Pharma is a global pharmaceutical company headquartered in Ballerup, Denmark, specializing in medical dermatology and thrombosis. Founded in 1908, the company is majority-owned by the LEO Foundation, which provides a stable platform for long-term research and development in skin health. Its product portfolio includes market-leading treatments for psoriasis, eczema, skin infections, and actinic keratosis, as well as anticoagulants for treating venous thromboembolism. LEO Pharma has expanded its focus toward innovative biologics, exemplified by the launch of tralokinumab for atopic dermatitis. With a presence in over 100 countries and a dedicated workforce of thousands, the company continues to advance the standard of care for patients with chronic and often debilitating skin conditions.